Lv41
550 积分 2024-03-18 加入
Allogeneic chimeric antigen receptor cell therapies for cancer: progress made and remaining roadblocks
3天前
已完结
CAR T cell killing requires the IFNγR pathway in solid but not liquid tumours
3个月前
已完结
Comparison of CAR T-cell vs. bispecific antibody as third- or later-line large B-cell lymphoma therapy: A Meta-analysis
3个月前
已完结
Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis
4个月前
已完结
In vivo CAR T-cell generation in non-human primates using lentiviral vectors displaying a multi-domain fusion ligand
4个月前
已完结
In vivo manufacture and manipulation of CAR-T cells for better druggability
4个月前
已完结
Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial final results
4个月前
已完结
Co-opting signalling molecules enables logic-gated control of CAR T cells
4个月前
已完结
Synapse-tuned CARs enhance immune cell anti-tumor activity
4个月前
已完结
Cancer therapy with antibodies
5个月前
已完结
皖公网安备34019202002308
